Newly elected AUA President E. Darracott Vaughan, Jr, MD, has committed to making research a top priority during his term. In part 1 of this exclusive two-part interview, he discusses the association's plans to enhance its research portfolio as well other key AUA initiatives. In part 2 next month, he addresses current practice issues facing urologists, including compliance and the work force. Dr. Vaughan is the James J. Colt professor and chairman of the department of urology at Weill Medical College of Cornell University, New York. UT Editorial Consultant Richard D. Williams, MD, professor and chairman of urology, University of Iowa, Iowa City, conducted the interview.
Cell-cycle risk score is predictive of ADT benefit in prostate cancer
May 17th 2024"Prolaris precisely describes the difference in metastasis outcomes for men receiving monotherapy (RT) vs multimodal therapy (RT+ADT), and further tells me precisely what the risk of death is for a man on surveillance," says Jonathan D. Tward, MD, PhD.